Narasimha Kumar Kopparapu

Title: Narasimha Kumar Kopparapu: Innovator in Biopharmaceutical Purification

Introduction

Narasimha Kumar Kopparapu is a notable inventor based in Andhra Pradesh, India. He has made significant contributions to the field of biopharmaceuticals, particularly in the purification processes of recombinant proteins. His innovative approach has led to advancements in the production of therapeutic proteins, which are crucial for various medical applications.

Latest Patents

Kopparapu holds a patent for an "Orthogonal process for purification of recombinant human parathyroid hormone (rhPTH) (1-34)." This invention outlines a novel method for preparing rhPTH (1-34), also known as teriparatide. The process involves constructing a unique nucleotide fragment that encodes a chimeric fusion protein. This protein is expressed in a controlled environment, utilizing a low feed rate lactose induction for optimized expression. The purification process described in the patent employs cation exchange chromatography followed by preparative chromatography, achieving a target protein purity of ≥99%. This method is not only effective but also cost-efficient and environmentally friendly.

Career Highlights

Kopparapu is associated with Usv Private Limited, where he continues to work on innovative solutions in the biopharmaceutical sector. His expertise in protein purification has positioned him as a valuable asset in his field. With a focus on developing methods that enhance the efficiency and purity of therapeutic proteins, he has contributed to the advancement of biopharmaceutical manufacturing.

Collaborations

Throughout his career, Kopparapu has collaborated with several professionals, including Shrikant Mishra and Meera Sankarankutty. These collaborations have fostered a productive environment for innovation and have led to the successful development of new biopharmaceutical processes.

Conclusion

Narasimha Kumar Kopparapu's contributions to the field of biopharmaceutical purification are noteworthy. His patented methods for producing high-purity recombinant proteins demonstrate his commitment to advancing medical science. His work continues to impact the biopharmaceutical industry positively.